A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells. - Wikidata - wikimedia - TriplyDB

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.

http://www.wikidata.org/entity/Q35829355

about

Androgen receptor molecular biology and potential targets in prostate cancer The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance The PIAS-like protein Zimp10 is essential for embryonic viability and proper vascular development Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements.Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancer.Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.Inhibition of prostate cancer cell growth by second-site androgen receptor antagonists.Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation.An Sp1 Modulated Regulatory Region Unique to Higher Primates Regulates Human Androgen Receptor Promoter Activity in Prostate Cancer Cells.Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer.Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cells.A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone.An AR-Skp2 pathway for proliferation of androgen-dependent prostate-cancer cells.Poly[3-(3, 4-dihydroxyphenyl) glyceric acid] from Comfrey exerts anti-cancer efficacy against human prostate cancer via targeting androgen receptor, cell cycle arrest and apoptosis.Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5' UTR.

P2860

Q24602861-BFB52255-2077-4D9B-AD7D-E2DDB229D321 Q28076745-B346769F-0E5A-4129-8358-04D38E38E0B6 Q28589178-212BD411-B945-422E-98A8-2576E6B81D83 Q33494984-CBA1A96A-B437-4A2F-AC0F-8E206810EC56 Q33632245-C0C55CE7-BE78-41E3-BDDB-C19680FF344E Q33688960-8EB33A6B-DF77-4F07-87F0-6585F038A402 Q33799771-3E0A60DF-7E92-4702-BE07-59C38E6819DC Q34189517-792365D2-B19B-4657-BA97-A837448F7AF5 Q34580343-DC206A63-A0A5-478C-A4EB-417539CA1300 Q34712118-3AF367D5-33B0-4FB3-B3AB-95E8CF6B34F2 Q35048965-5D70C57F-FFCE-44E1-84C4-F1330B619730 Q35109795-E67573A2-BA7D-41D1-9271-746CBEB74E9E Q35846835-60F5EB1F-20BC-4661-B15C-BEAF303FE523 Q36777961-F137AE9B-F050-4176-8FFB-28435A3E8FD4 Q36779605-6AA6562F-5480-47F9-AEDB-A12C9B85264E Q37086672-E699D6C0-95D4-4415-8EFB-22697D72DF13 Q37098796-4B04FA2F-1FD7-486C-9C70-BE25541865F3 Q37161795-67D17429-FCCD-4C3F-B2C2-7C4107EDBD69 Q37274341-BFC9F53E-CF4A-4FDE-BB1C-8A108B06994F Q37322621-BA5732C1-6655-42FC-8F02-2FE5C38FFDC8 Q37456966-2CAF11D1-D5A1-4B1E-A739-4FBA9B5ED3F2 Q37551286-D33B31E5-31EC-4020-8EE7-3E9B01690741 Q38271452-E602A683-FBD9-4D9F-AD8F-47E3F2D15188 Q38829510-E1C225BE-17F5-4DBD-9660-6CF148FB47F7 Q39384179-0D1278C6-D8D1-43C9-95B4-1EC5ED0C8376 Q39405509-1914F5C6-A59A-4E25-AB1F-5C5441BB6F90 Q39427379-5BA057BB-5A21-4AF6-A20C-6E2B14926159 Q39484147-08DD3A4A-EC0D-4A51-A1A5-142027FEEFBA Q39802064-E0D4B20F-7F36-436C-9C47-4F0273FBA739 Q39961194-629F1B00-696D-42DB-97DB-29C9F0FABDA8 Q41129816-900C1B59-B2FD-490A-A00D-7226B5E77557 Q41839868-DA0884AD-3DBB-4936-A572-20453B59D8A3 Q42878519-0426B5C7-4274-4E4F-832C-30E220069F99

P2860

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.

http://www.wikidata.org/entity/Q35829355

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

A promoting role of androgen r ...... nsitive prostate cancer cells.

@ast

A promoting role of androgen r ...... nsitive prostate cancer cells.

@en

type

label

A promoting role of androgen r ...... nsitive prostate cancer cells.

@ast

A promoting role of androgen r ...... nsitive prostate cancer cells.

@en

prefLabel

A promoting role of androgen r ...... nsitive prostate cancer cells.

@ast

A promoting role of androgen r ...... nsitive prostate cancer cells.

@en

P1433

Q35829355-34F58A8C-DC57-4EDA-8AE6-CFAE7E97252E

P1476

Q35829355-3A6B5481-67EA-4075-B216-5CAE7158ADA6

P2093

Q35829355-03277A9F-6AAC-4589-A6D4-2554DFCDB8E7

Q35829355-204CEF0A-7A3B-40BB-905B-AAECA05AB9FD

Q35829355-774AB7CB-C15F-4E12-A41E-CC09E924FF10

Q35829355-878D4117-2606-40C4-BC12-DFFA3CBE2763

Q35829355-95893D39-5F39-4CDB-B3FE-717C749EDE13

Q35829355-A54AC499-CEDF-4FD2-AFC4-FC7BBCAD1D56

P2860

Q35829355-03A1D68C-9021-4B78-B9AF-2AB980371C09

Q35829355-1B5A4917-9EC2-4890-A293-11ED6D8C2EA1

Q35829355-1D4E2870-9217-486D-885D-88FDC70B754A

Q35829355-1EED00B4-57F1-4059-B198-5A61657D000E

Q35829355-22FFD8F9-21E1-4D6E-8E8E-291118987774

Q35829355-25CD95B7-7AB5-4980-931B-76F942CCCD1B

Q35829355-2B133637-B594-43FA-968F-DCE6B2F92FA3

Q35829355-3701B724-D191-4202-BD1C-F5B25EAE8AFB

Q35829355-3B605B3E-48FE-40D9-9F85-43A489D07AB0

Q35829355-4C01B048-3DCA-4B14-A6DA-BA2FF83B4C95

P304

Q35829355-912898D8-5A08-4A1C-9EA8-6B435BC75020

P31

Q35829355-FDE7E1DD-80B4-452B-AC85-46585A9BC834

P356

Q35829355-71765325-2826-4CED-9B7C-37C691DFA654

P407

Q35829355-260A4FB1-1F99-45CB-A7D0-C79840D7B9F5

P433

Q35829355-1EC22AA2-940A-4817-B682-5C261E15BE57

P478

Q35829355-54C79933-6CA8-4445-BF09-296339889CB5

P577

Q35829355-661FDF53-3FE6-485B-8EF9-9F5F53663D29

P5875

Q35829355-C4BAB466-75B5-4FF8-95F3-CDFABE10CAAA

P698

Q35829355-13092632-57BD-4730-A8F9-FB0A2C5A7723

P932

Q35829355-03829858-4332-4111-8BC3-6C73EB363F25

P356

P1433

Nucleic Acids Research

P1476

A promoting role of androgen r ...... nsitive prostate cancer cells.

@en

P2093

Hongjuan Zhao

http://www.w3.org/2001/XMLSchema#string

James D Brooks

http://www.w3.org/2001/XMLSchema#string

Jason Beliakoff

http://www.w3.org/2001/XMLSchema#string

Tzu-Huey Li

http://www.w3.org/2001/XMLSchema#string

Yue Peng

http://www.w3.org/2001/XMLSchema#string

Zijie Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Androgen receptor interacts with a novel MYST protein, HBO1

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

A simplified system for generating recombinant adenoviruses

Linking beta-catenin to androgen-signaling pathway

Molecular determinants of resistance to antiandrogen therapy

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

A third-generation lentivirus vector with a conditional packaging system

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells.

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.

The role of the androgen receptor in the development and progression of prostate cancer.

P304

2767-2776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKM198

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51390271

http://www.w3.org/2001/XMLSchema#string

P698

17426117

http://www.w3.org/2001/XMLSchema#string

P932

1885678

http://www.w3.org/2001/XMLSchema#string